Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
November 29 and 30, 2016 - The Lotte New York Palace, New York - USA
September 20 -21, 2016 - ConventionPoint SIX Swiss Exchange, Zürich - Switzerland
August 23, 2016 - Marriott Hotel, Zurich, Switzerland